JGCM
ABBV icon

Joseph Group Capital Management’s AbbVie ABBV Stock Holding History

Joseph Group Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Sell
421
-767
-65% -$165K 0.02% 97
2026
Q1 		$258K Buy
1,188
+162
+16% +$35.9K 0.06% 62
2025
Q4 		$234K Buy
1,026
+156
+18% +$35.5K 0.06% 62
2025
Q3 		$201K Buy
+870
New +$177K 0.06% 60

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Joseph Group Capital Management's ABBV Position: Q2 2026 in Review

Joseph Group Capital Management reduced its AbbVie (ABBV) stake by 65% in Q2 2026, selling an estimated $165K and leaving 421 shares worth $106K. The position accounts for 0.02% of the portfolio, ranked #97.

Joseph Group Capital Management first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. The position peaked at $258K in Q1 2026. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Joseph Group Capital Management held 421 shares of AbbVie worth $106K as of Q2 2026.
  • Joseph Group Capital Management sold 767 AbbVie shares in Q2 2026, an estimated $165K.
  • AbbVie made up 0.02% of Joseph Group Capital Management's portfolio in Q2 2026, its #97 holding.
  • Joseph Group Capital Management first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • Joseph Group Capital Management's AbbVie position peaked at $258K in Q1 2026.
  • 4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Joseph Group Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.